GlassScriptPhysician profile
Nancy S Noel
NPI 1588648836
$1,092.39
in general payments reported to CMS, 2019-2025
19 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $50.35 · 2023: $148 · 2024: $332 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $294.08 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $98.31 | 2019-2025 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $89.11 | 2019-2024 | Airsupra, Farxiga |
| Abbvie INC. | $81.57 | 2019-2025 | |
| Pfizer INC. | $74.61 | 2019-2024 | |
| Astellas Pharma US INC | $73.54 | 2019-2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.68 | 2019 | |
| Lilly USA, LLC | $56.18 | 2023-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $43.88 | 2024-2025 | |
| Shire North American Group INC | $42.15 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $35.90 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $25.54 | 2024 | Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $25.36 | 2024 | Ingrezza |
| Tempus Ai, INC | $18.55 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.10 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $16.09 | 2019 | |
| Phathom Pharmaceuticals, INC. | $15.80 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $12.04 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.